L-arginine supplementation in type II diabetic rats preserves renal function and improves insulin sensitivity by altering the nitric oxide pathway

International Journal of Endocrinology

Volumn 2014, Issue , 2014, Pages

  Claybaugh, Taylor ^a   Decker, Sarah ^a   McCall, Kelly ^a   Slyvka, Yuriy ^a   Steimle, Jerrod ^a   Wood, Aaron ^a   Schaefer, Megan ^a   Thuma, Jean ^a   Inman, Sharon ^a  

^a OHIO UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893874836     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2014/171546     Document Type: Article

References (22)

1. Remuzzi G., Macia M., Ruggenenti P., Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study. Journal of the American Society of Nephrology 2006 17 4, supplement 2 S90 S97 2-s2.0-33645462551 10.1681/ASN.2005121324
2. Hostetter T. H., Troy J. L., Brenner B. M., Glomerular hemodynamics in experimental diabetes mellitus. Kidney International 1981 19 3 410 415 10.1038/ki.1981.33 2-s2.0-0019460233 (Pubitemid 11112621)
3. Fowler M. J., Microvascular and macrovascular complications of diabetes. Clinical Diabetes 2008 26 2 77 82 2-s2.0-42349087252 10.2337/diaclin.26.2.77 (Pubitemid 351556223)
4. Blouet C., Mariotti F., Mathe V., Tome D., Huneau J.-F., Nitric oxide bioavailability and not production is first altered during the onset of insulin resistance in sucrose-fed rats. Experimental Biology and Medicine 2007 232 11 1458 1464 2-s2.0-41549164486 (Pubitemid 350220544)
5. Buchwalow I., Schnekenburger J., Tiemann K., L-arginine-NO-cGMP signaling pathway in pancreatitis. Scientific Reports 2013 3 article 1899 10.1038/srep01899
6. Bourgoin F., Bachelard H., Badeau M., Mélançon S., Pitre M., Larivière R., Nadeau A., Endothelial and vascular dysfunctions and insulin resistance in rats fed a high-fat, high-sucrose diet. American Journal of Physiology: Heart and Circulatory Physiology 2008 295 3 H1044 H1055 2-s2.0-54049087474 10.1152/ajpheart.00516.2008
7. Shaker O., Ghallab N. A., Hamdy E., Sayed S., Inducible nitric oxide synthase (iNOS) in gingival tissues of chronic periodontitis with and without diabetes: immunohistochemistry and RT-PCR study. Archives of Oral Biology 2013 58 10 1397 1406 10.1016/j.archoralbio.2013.05.003
8. Schiaich M. P., Schmitt D., Ott C., Schmidt B. M., Schmieder R. E., Basal nitric oxide synthaseactivity is a major determinant of glomerular hemodynamics in humans. Journal of hypertension 2008 26 1 110 116 (Pubitemid 350294855)
9. Lorin J., Zeller M., Guilland J.-C., Cottin Y., Vergely C., Rochette L., Arginine and nitric oxide synthase: regulatory mechanisms and cardiovascular aspects. Molecular Nutrition & Food Research 2013 10.1002/mnfr.201300033
10. Luiking Y. C., Have G. A. T., Wolfe R. R., Deutz N. E., Arginine de novo and nitric oxide production in disease states. American Journal of Physiology: Endocrinology and Metabolism 2012 303 10 E1177 E1189 10.1152/ajpendo.00284.2012
11. Jabłecka A., Bogdański P., Balcer N., Cieślewicz A., Skołuda A., Musialik K., The effect of oral L-arginine supplementation on fasting glucose, HbA1c, nitric oxide and total antioxidant status in diabetic patients with atherosclerotic peripheral arterial disease of lower extremities. European Review for Medical and Pharmacological Sciences 2012 16 3 342 350 2-s2.0-84859925204
12. Slyvka Y., Inman S. R., Malgor R., Jackson E. J., Yee J., Oshogwemoh O., Adame J., Nowak F. V., Protective effects of antioxidant-fortified diet on renal function and metabolic profile in obese zucker rat. Endocrine 2009 35 1 89 100 2-s2.0-63449140516 10.1007/s12020-008-9121-7
13. Dutta K., Podolin D. A., Davidson M. B., Davidoff A. J., Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance. Diabetes 2001 50 5 1186 1192 2-s2.0-0035039703 (Pubitemid 32374552)
14. Betz B., Möller-Ehrlich K., Kress T., Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency. Translational Research 2013 162 2 67 76 10.1016/j.trsl.2013.04.005
15. Aiello S., Remuzzi G., Noris M., Nitric oxide/endothelin balance after nephron reduction. Kidney International Supplements 1998 65 S63 S67 2-s2.0-0032043634 (Pubitemid 28204567)
16. Toba H., Sawai N., Morishita M., Murata S., Yoshida M., Nakashima K., Morita Y., Kobara M., Nakata T., Chronic treatment with recombinant human erythropoietin exerts renoprotective effects beyond hematopoiesis in streptozotocin-induced diabetic rat. European Journal of Pharmacology 2009 612 1-3 106 114 2-s2.0-65549121743 10.1016/j.ejphar.2009.03.065
17. Tunctan B., Korkmaz B., Sari A. N., Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91phox to the protective effect of 5, 14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock. Nitric Oxide 2013 33 18 41 10.1016/j.niox.2013.05.001
18. Morris S. M. Jr., Gao T., Cooper T. K., Kepka-Lenhart D., Awad A. S., Arginase-2 mediates diabetic renal injury. Diabetes 2011 60 11 3015 3022 2-s2.0-80755152815 10.2337/db11-0901
19. Bellinghieri G., Santoro D., Mallamace A., Savica V., L-arginine: a new opportunity in the management of clinical derangements in dialysis patients. Journal of Renal Nutrition 2006 16 3 245 247 2-s2.0-33745665332 10.1053/j.jrn.2006.04.004 (Pubitemid 43974997)
20. di Paola R., Impellizzeri D., Mondello P., Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice. Shock 2012 38 4 356 366
21. Peeri M., Habibian M., Azarbayjani M. A., Hedayati M., Protective effect of aerobic exercise against L-name-induced kidney damage in rats. Archives of Industrial Hygiene and Toxicology 2013 64 2 43 49
22. 2+-sensing receptor expression and signaling in mouse mesenteric arteries. The Journal of Pharmacology and Experimental Therapeutics 2013 346 1 38 47 10.1124/jpet.113.205534